Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Detailed Action
This office action is in response to applicant’s communication filed on 8/14/26. Claims 1-4, 6-7, 9-11 and 13-15 are pending. Claims 5, 8, 12 and 16 have been cancelled.
Claims 3 and 17-19 remain withdrawn. Claim 3 does not read on applicant’s elected species. Thus, claims 1-2, 4, 6-7, 9-11 and 13-15 are being examined in this Office Action.
Due to applicant's claim amendments filed 7/14/26, the objection to claim 1 and the rejections under 35 U.S.C. 112, second paragraph, filed 3/16/26 have been withdrawn. New rejections under 35 U.S.C. 112, second paragraph, necessitated by the amendment, are set forth below. Due to the replacement drawing sheet and the amended paragraphs [0071] and [0073] filed 7/14/26, the objections to the drawings and to the disclosure filed 3/16/26 have been withdrawn.
Additionally, the examiner acknowledges the typographical error in the 103 rejection over Fuji et al. in view of Phan et al., in the office action filed 3/16/26, in which claims 9 and 11 were inadvertently omitted. This has been corrected below, and claims 9 and 11 are included in the 103 rejection over the same references, Fuji et al. in view of Phan et al.
Claim Rejections – 35 USC 112.2
The following is a quotation of the second paragraph of 35 U.S.C. 112:
The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention.
Claims 1-2, 4, 6-7, 9-11 and 13-15 are rejected under 35 U.S.C. 112, second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which applicant regards as the invention.
Claim 1 is indefinite because of the claim language "L1 can be a n-alkyl group…or L1 is absent" in the definition of the lithium single-ion monomer. The word "can" is permissive. It is not clear if L1 is limited to the listed groups or if L1 may be some other group. The examiner recommends "L1 is a n-alkyl group…or L1 is absent".
Claim 1 is indefinite because of the claim language "and is converted from a sulfonate compound of formula". It is not clear if the conversion of the sulfonate compound to the sulfonyl chloride compound is a step of the claimed method, or if the claim language only describes the source of the sulfonyl chloride compound. Claim 9 recites "the conversion from sulfonate to sulfonyl chloride is performed using…". Claim 9 treats the conversion as a step. For purposes of examination, the claim is read both ways. The examiner recommends an active step, for example: "converting a sulfonate compound of formula…to the sulfonyl chloride compound; and simultaneously reacting the sulfonyl chloride compound with…".
The dependent claims are rejected as being dependent on a rejected claim.
Appropriate correction is required.
Claim Rejections – 35 USC 103
In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status.
The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action:
A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102 of this title, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made.
The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows:
1. Determining the scope and contents of the prior art.
2. Ascertaining the differences between the prior art and the claims at issue.
3. Resolving the level of ordinary skill in the pertinent art.
4. Considering objective evidence present in the application indicating obviousness or nonobviousness.
This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention.
Claims 1-2, 4, 6-7, 9-11 and 13-15 remain rejected under 35 U.S.C. 103(a) as being unpatentable over Fuji et al. (WO 2018021185, pub date 02/01/2018; the English translation is used herein), in view of Phan et al. (Polym. Chem., 2016, 7, 6901).
Determination of the Scope and Content of the Prior Art
(MPEP §2141.01)
Fuji et al. exemplifies the synthesis of lithium 4-styrenesulfonyl(trifluoromethylsulfonyl)imide. This product reads on applicant's lithium single-ion monomer when R1=R2=R3=H, R4 is a phenyl group, L1 is absent, Rf=CF3 and M=Li+. (page 8, Example 1) The structure is below:
PNG
media_image1.png
150
64
media_image1.png
Greyscale
Fuji et al. exemplifies adding lithium hydride (reads on applicant's quenching base and lithium cation source) and acetonitrile to a flask. A solution of trifluoromethanesulfonamide (reads on applicant's fluorinated sulfonamide compound, when RA=CF3) is added. Then a solution of 4-styrenesulfonyl chloride (reads on applicant's sulfonyl chloride compound when R1=R2=R3=H, R4 is a phenyl group, L1 is absent) is added. The mixture is stirred at room temperature for 17 hours. The inorganic salts are removed by filtration. The solvent is distilled off. The lithium 4-styrenesulfonyl(trifluoromethylsulfonyl)imide is obtained in 75% yield. (page 8, Example 1, 1st and 2nd paragraphs)
Fuji et al. teaches lithium hydride, lithium hydroxide or sodium carbonate as the particularly preferred base to react with the sulfonamide. (page 4, 1st paragraph)
Fuji et al. teaches the sulfonyl halide (4) (see structure below) has an R3 group that is 4-vinylphenyl, (meth)acryloyloxy or (meth)acryloyloxyalkyl, with 4-vinylphenyl and 3-(meth)acryloyloxypropyl listed as specific examples. Thus Fuji et al. teaches the equivalency of the 4-vinylphenyl (styrene) carbon backbone and the 3-(meth)acryloyloxypropyl (propyl (meth)acrylate) carbon backbone for the sulfonyl halide. (page 2, last paragraph to page 3, 1st paragraph; page 3, last paragraph to page 4, 1st paragraph)
PNG
media_image2.png
112
168
media_image2.png
Greyscale
Fuji et al. teaches the by-product halide (lithium chloride) is removed from the sulfonimide by filtration of the inorganic salts and by extraction. (page 5, 2nd paragraph; page 8, Example 1, 1st paragraph)
Fuji et al. teaches the sulfonimide is a monomer that polymerizes. Fuji et al. teaches the use of silica gel, chromatographic analysis and gel permeation chromatography (GPC) in their synthesis and analysis procedures. (page 6, 3rd paragraph; page 7, 1st and 4th paragraphs; page 10, Comparative Example 3)
Fuji et al. does not use an amine or any other nitrogen-based organic cation in Example 1. (page 8, Example 1)
With regard to applicant's limitation for a simultaneous reaction, Fuji et al. adds the lithium hydride, the trifluoromethanesulfonamide and the 4-styrenesulfonyl chloride to the same reaction vessel. The mixture is then stirred for 17 hours to react. Thus the sulfonyl chloride reacts with the fluorinated sulfonamide and the lithium base at the same time, in the same pot. This reads on applicant's simultaneous reaction. Even if it does not, it would be obvious to add all the reactants to a single reaction vessel for a simultaneous reaction since, as indicated in MPEP 2144.04 IV. C., the order of prior art process steps is prima facie obvious in the absence of new or unexpected results.
Fuji et al. uses lithium hydride as the base. Fuji et al. does not use an amine or form an ammonium salt and thus does not require the synthesis of a nitrogen-based organic cation.
With regard to applicant's limitations in claims 13 and 14 for purifying the lithium single-ion monomer and removing the LiCl byproduct, Fuji et al. filters off the inorganic salts, distills off the solvent and extracts the sulfonimide away from the lithium chloride. This reads on these limitations. With regard to the silica gel flash chromatography of claim 14, it would be obvious to purify the lithium single-ion monomer by silica gel flash chromatography, since Fuji et al. uses silica gel and chromatographic analysis in their procedures, and since silica gel flash chromatography is a standard purification procedure in synthetic organic chemistry. The selection of a known purification technique for its intended purpose is prima facie obvious.
Ascertainment of the Difference Between Scope the Prior Art and the Claims
(MPEP §2141.012)
Fuji et al. is deficient in the sense that it does not teach that the sulfonyl chloride compound is converted from a sulfonate compound, or that the conversion uses thionyl chloride or oxalyl chloride (claims 1, 9 and 11).
Fuji et al. is also deficient in the sense that it does not exemplify applicant's elected species for the lithium single-ion monomer, with a 3-acryloyloxypropyl carbon backbone (also known as propyl acrylate carbon backbone).
Instead Fuji et al. exemplifies the 4-vinylphenyl carbon backbone (also known as styrene carbon backbone). However, as noted above, Fuji et al. does list 3-(meth)acryloyloxypropyl as an R3 group for the sulfonyl halide.
Phan et al. teaches the synthesis of sulfonyl(trifluoromethane sulfonyl)imide monomers (which correspond to applicant's single-ion monomer) from the corresponding sulfonyl chloride monomer and trifluoromethanesulfonamide. (abstract)
Phan et al. exemplifies the conversion of potassium 3-sulfopropyl acrylate (reads on applicant's sulfonate compound when R1=R2=R3=H, R4 is an ester group, L1 is propyl and M=K+; also reads on the first sulfonate of claim 11 when R=H) to 3-(chlorosulfonyl)propyl acrylate (reads on applicant's sulfonyl chloride compound and on the first sulfonyl chloride of claim 10 when R=H) with oxalyl chloride and N,N-dimethylformamide in acetonitrile. The 3-(chlorosulfonyl)propyl acrylate is then reacted with trifluoromethanesulfonamide to give the sulfonyl(trifluoromethane sulfonyl)imide monomer (ASTFSIK). (page 6903, 1st column, last paragraph to 2nd column, 1st paragraph; page 6904, Scheme 2)
Phan et al. teaches the 3-sulfopropyl (meth)acrylate potassium salts are commercially available and are converted into the sulfonyl chloride derivatives by reaction with oxalyl chloride in the presence of DMF as the catalyst (Vilsmeier–Haack reaction). (page 6904, 2nd column, 1st paragraph)
Phan et al. teaches the same route for the styrene monomer. 4-Vinylbenzenesulfonyl chloride is synthesized, then reacted in situ with trifluoromethanesulfonamide. Cation exchange with LiOH gives the lithium styrene-STFSI monomer. Phan et al. also teaches that Li2CO3 or LiOH is used in the synthesis of the lithium styrene monomer (SSTFSILi). (page 6904, 2nd column, 1st and 2nd paragraphs)
Phan et al. teaches the equivalency of the propyl acrylate carbon backbone (ASTFSIK) and the styrene carbon backbone (SSTFSILi) for the sulfonyl(trifluoromethane sulfonyl)imide monomers. Phan et al. polymerizes each monomer. (page 6902, Scheme 1; page 6904, Table 1; page 6905, Table 2)
See Phan et al. structures below:
PNG
media_image3.png
70
164
media_image3.png
Greyscale
(ASTFSIK) Potassium salt monomer with a 3-acryloyloxypropyl carbon backbone (also known as propyl acrylate carbon backbone)
PNG
media_image1.png
150
64
media_image1.png
Greyscale
(SSTFSILi) Lithium salt monomer with a 4-vinylphenyl carbon backbone (also known as styrene carbon backbone)
Phan et al. teaches the conversion of the sulfonyl chloride reactant (first compound in the following scheme below) to the resulting (ASTFSIK) product (last compound in the following scheme) (see scheme below). Thus, Phan et al. teaches the formation of (ASTFSIK), which contains the propyl acrylate carbon backbone in the sulfonimide derivative product (which corresponds to applicant’s single-ion monomer), by the reaction of the sulfonyl chloride (also known as sulfonyl halide) reactant. (page 6904, Scheme 2)
PNG
media_image4.png
188
526
media_image4.png
Greyscale
Finding of Prima Facie Obviousness Rationale and Motivation
(MPEP §2142-2143)
Therefore, it would be prima facie obvious to one of ordinary skill in the art at the time of the invention, to obtain the sulfonyl chloride compound of Fuji et al. by converting the corresponding sulfonate compound with oxalyl chloride, with a reasonable expectation of success, since Phan et al. teaches that the sulfonate salts are commercially available and are converted to the sulfonyl chloride by oxalyl chloride and DMF, and since Phan et al. teaches the resulting sulfonyl chloride is then reacted with trifluoromethanesulfonamide to give the same type of sulfonimide monomer made by Fuji et al.
It would also be prima facie obvious to substitute Phan et al.'s propyl acrylate carbon backbone for Fuji et al.'s styrene carbon backbone with a reasonable expectation of success, since Phan et al. teaches the equivalency of the propyl acrylate carbon backbone and the styrene carbon backbone for their sulfonimide monomers, and since Fuji et al. lists both 4-vinylphenyl and 3-(meth)acryloyloxypropyl as R3 groups for the sulfonyl halide.
It would also be obvious to substitute lithium hydroxide for lithium hydride with a reasonable expectation of success, since Fuji et al. teaches lithium hydride and lithium hydroxide as the particularly preferred bases for the same reaction.
Note that an express suggestion to substitute one equivalent component or process for another is not necessary to render such substitution obvious. In re Fout, 675 F.2d 297, 213 USPQ 532 (CCPA 1982).
Absent evidence of unexpected results for applicant's particular process steps, it would be obvious to convert the sulfonate compound to the sulfonyl chloride compound with oxalyl chloride, and then to react the sulfonyl chloride compound simultaneously with trifluoromethanesulfonamide and lithium hydroxide in one pot, to give the lithium single-ion monomer with a 3-acryloyloxypropyl carbon backbone, with a reasonable expectation of success.
Response to Arguments
Applicant's arguments have been considered but are not persuasive for the following reasons:
The examiner acknowledges applicant's argument that Fuji et al. does not disclose a lithium single-ion monomer of the formula now recited in claim 1, and that Phan et al. fails to cure this deficiency.
The examiner does not agree with applicant's arguments. Applicant does not identify any variable of the recited formula that Fuji et al.'s product fails to meet. Fuji et al.'s lithium 4-styrenesulfonyl(trifluoromethylsulfonyl)imide is within the recited formula. R1, R2 and R3 are each H. R4 is a phenyl group. L1 is absent. Rf is CF3. M is Li+. (page 8, Example 1) Fuji et al. also teaches lithium as the particularly preferred cation and trifluoromethyl as the particularly preferred R1 (Rf) group. (page 2, 2nd to 3rd paragraphs)
With regard to the new limitation that the sulfonyl chloride compound is converted from a sulfonate compound, this limitation is taught by Phan et al., as set forth above. Phan et al. converts the commercially available potassium 3-sulfopropyl acrylate to 3-(chlorosulfonyl)propyl acrylate with oxalyl chloride and DMF. (page 6903, 1st column, last paragraph; page 6904, 2nd column, 1st paragraph) Phan et al. is relied upon for this teaching.
Conclusion
No claim is allowed.
Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a).
A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any extension fee pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the date of this final action.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to Jennifer Cho Sawyer whose telephone number is (571) 270 1690. The examiner can normally be reached on Monday-Friday 9 AM - 6 PM PST.
If attempts to reach the examiner by telephone are unsuccessful, the examiner's supervisor, Renee Claytor can be reached on (571) 272-8394. The fax phone number for the organization where this application or proceeding is assigned is 571-274-1690.
Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/JENNIFER C SAWYER/Examiner, Art Unit 1691
/RENEE CLAYTOR/Supervisory Patent Examiner, Art Unit 1691